Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

i_opioidsubstance_2017a_2017-09-12t09:06:11z9 Hearing Summary

Date: 09/12/2017

Location: RM 271

Final

Public Comment



OPIOID AND OTHER SUBSTANCE USE DISORDERS


Votes: View--> Action Taken:
<none> <none>











03:44 PM -- Public Comment



Representative Pettersen opened the meeting for public testimony.



3:45 PM -- Nancy Steinfurth, Liver Health Connection, testified regarding Hepatitis C infections resulting from syringe use. She recommended increased syringe exchanges in the state, increased Hepatitis C testing, and eliminating barriers to treatment for Hepatitis C.








Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details